AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,686,000 | +111.3% | 28,177 | -0.8% | 0.01% | +133.3% |
Q3 2019 | $798,000 | -24.4% | 28,414 | +1.9% | 0.00% | -25.0% |
Q2 2019 | $1,056,000 | +14.0% | 27,887 | +17.6% | 0.00% | 0.0% |
Q1 2019 | $926,000 | +77.4% | 23,722 | -3.1% | 0.00% | +100.0% |
Q4 2018 | $522,000 | -38.9% | 24,489 | +13.5% | 0.00% | -33.3% |
Q3 2018 | $854,000 | +7.2% | 21,580 | +3.5% | 0.00% | 0.0% |
Q2 2018 | $797,000 | +106.5% | 20,858 | +62.6% | 0.00% | +200.0% |
Q1 2018 | $386,000 | +11.6% | 12,829 | +15.9% | 0.00% | 0.0% |
Q4 2017 | $346,000 | +20.6% | 11,068 | +8.2% | 0.00% | 0.0% |
Q3 2017 | $287,000 | +58.6% | 10,231 | +8.1% | 0.00% | 0.0% |
Q2 2017 | $181,000 | +212.1% | 9,466 | +179.6% | 0.00% | – |
Q1 2017 | $58,000 | – | 3,385 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,204,615 | $37,644,219,000 | 39.61% |
Casdin Capital, LLC | 400,000 | $12,500,000 | 3.04% |
Opaleye Management Inc. | 210,000 | $6,652,000 | 2.13% |
Orbimed Advisors | 4,129,638 | $129,051,000 | 1.63% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,190,516 | $37,204,000 | 1.46% |
Redmile Group, LLC | 929,326 | $29,041,000 | 1.26% |
Cormorant Asset Management, LP | 337,876 | $10,559,000 | 1.10% |
Perceptive Advisors | 781,309 | $24,416,000 | 0.81% |
Rock Springs Capital Management LP | 525,000 | $16,406,000 | 0.74% |
Virtus ETF Advisers LLC | 11,898 | $372,000 | 0.47% |